{"ticker": {"uuid": "9276c15a-1bc6-44d0-94fe-258f0dfd97a7", "symbol": "CBUS", "name": "Cibus Global LLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Cibus (CBUS) Welcomes Landmark EU Crop Breeding Decision", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cibus-cbus-welcomes-landmark-eu-103305040.html", "source_name": "Insider Monkey", "published_at": "2026-07-14T10:33:05+00:00", "published_display": "14 Jul 2026 10:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/europe-recognizes-nature-based-plant-120500250.html", "source_name": "GlobeNewswire", "published_at": "2026-06-17T12:05:00+00:00", "published_display": "17 Jun 2026 12:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Europe opens fast lane for non-GMO crops; Cibus traits expected to fit", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPR1dZc1A1M0RJalJmTU5tVTB5Z3hNbG4tTXhBTXNlV2NFMTZCY09EMGdiOGRkdl84YWV0S1dYYnJDYUhNZ01FQWZGZVlvQlVVUEloWDh4SktmQXJRY3V1a0ZIWGp4eTMxX1lqV0d3RU82X2J6Q2xjcVppMEdSSWtMdUplRy1WUXJuT0Z2Qi00YTloYWFSUnpyaXZmaHBvdlBZMk9vS3BDdW5kd1FPakZtYWx2YmtQVm1q?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) taps Farmland LP founder Craig Wichner as CEO", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNTXd1TG1xaFZSTjZaa0M5dEhvMlpaSjhmLTg4bm5hRWVsTE1tWnJfaXh2eE9tVzlqS0xoM2ZVaWJUeWs1cVVTSDZjSndqNnhWelZEQWZRd3R3QnZxZnBOTXdCWUdFSEZ6OEVlLXZ2cFREVGxFTzJ3UDExWldpUEV4VHZhSWRYcnlkUEdKZ0p4SHlDWndCb1Q3ZWxJZVQ2UzA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cibus-names-agricultural-biotechnology-leader-223000039.html", "source_name": "GlobeNewswire", "published_at": "2026-06-08T22:30:00+00:00", "published_display": "08 Jun 2026 22:30", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Farmland investor Craig Wichner becomes Cibus CEO, targets commercialization", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOc3hBX25ucXE4QzZSSVdWQW1XQ01tSmV3NmVRZ05md2xwVmNPVjgwdS1Da1NPLW84MlQyX2dyZjlyWmRueGNGYUtJSzlTMVBOb243NWRDLVlkaU1HM2l6RHM0OXhnYzFBQ2g4Qmo4V0xqRVYxVk9MT3dEUVFmRlRlMndsdGtMdWpnQk0zTy05dWVBLTNYQlk1Y2hLWTdIU1E3b0dndEdna1F2VnpDaUxCd2g1T09Vd2U1eEFjVkVDNUY?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus appoints Craig Wichner as chief executive officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPSDZMUTc2V1Y1X2FqTWF5UXZzajFDOUp5SjJrYTNZSDJBUlJWNXY1Uk0tRVZxT0FqTlQyT0x6eTdNcEw3Rzh6QXpCYUtaNTJzMWw3TWJ6eEJ2SlhXSUVVUFlhaWZoNFhtN3lLNHdoSHRScjZFNzltRlJhdjNRNmpPYjlaT2ttOXBJVHVUVm1MVnRqSlV1aERWem1UbDl6U3pPOHZ1QWQ5bmpvT0N2b1Y5MEt3?oc=5", "source_name": "Investing.com", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (CBUS) 2026 meeting backs board slate, executive pay and BDO", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQWGlieEhDWVpyUVFSSmpLTlhrUmVXV3NzUkpTTF93MGdLMC11QjZwQXdDUl82MHhPNndOTi1Sc3ZqQ3dCMEZxZkFDMUFOODNDTGhaRkxCUlhRRS14ZU53LVZoZ0RadmdIeTJtRGlpOEFUUWd1Qk41aFpFVXg1NzVackNmSUhMcjdIVWRYcEdQYnhjMUE4bWhLUEZjSElySE0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[EFFECT] Cibus, Inc. SEC Filing", "summary": "This article announces an SEC filing by Cibus, Inc. (CBUS) for a Form EFFECT, which is a Type S-3 Shelf Registration Statement. The filing has a neutral impact and sentiment and its effectiveness date was May 22, 2026, at 4:00 P.M. The article also provides recent news and other ", "url": "https://www.stocktitan.net/sec-filings/CBUS/effect-cibus-inc-sec-filing-468c179c9750.html", "source_name": "Stock Titan", "published_at": "2026-05-27T07:40:30", "published_display": "27 May 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) files at\u2011the\u2011market $50M shelf with Jefferies", "summary": "Cibus (NASDAQ: CBUS) has filed an at-the-market (ATM) shelf prospectus to offer and sell up to $50 million of its Class A Common Stock through Jefferies LLC. The company plans to use the net proceeds for working capital and general corporate purposes, including the further develo", "url": "https://www.stocktitan.net/sec-filings/CBUS/424b2-cibus-inc-prospectus-supplement-8c8042db9781.html", "source_name": "Stock Titan", "published_at": "2026-05-23T19:09:51", "published_display": "23 May 2026 19:09", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (CBUS) registers 10.74M shares issuable on warrants \u2014 issuer to receive proceeds", "summary": "Cibus, Inc. (CBUS) has registered 10,738,040 shares of Class A Common Stock obtainable through the exercise of existing warrants. The company expects to receive approximately $26.6 million in proceeds if all warrants are fully exercised, which will be allocated towards working ca", "url": "https://www.stocktitan.net/sec-filings/CBUS/424b3-cibus-inc-prospectus-filed-pursuant-to-rule-424-b-3-65562dcff148.html", "source_name": "Stock Titan", "published_at": "2026-05-23T05:40:11", "published_display": "23 May 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus Reports First Quarter Financial Results and Provides Business Update", "summary": "Cibus, Inc. announced its financial results for the first quarter ended March 31, 2026, highlighting continued momentum in its Rice herbicide tolerance and Sustainable Ingredients programs. The company reported a reduced net loss of $21.2 million compared to $49.4 million in the ", "url": "https://sg.finance.yahoo.com/news/cibus-reports-first-quarter-financial-200500136.html", "source_name": "Market source", "published_at": "2026-05-15T14:09:40", "published_display": "15 May 2026 14:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/90e7be81-b482-3d6f-acc0-2680e3086f1b/cibus%2C-inc.-q1-2026-earnings.html", "source_name": "Moby", "published_at": "2026-05-15T12:30:00+00:00", "published_display": "15 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cibus Inc (CBUS) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/cibus-inc-cbus-q1-2026-050227266.html", "source_name": "GuruFocus.com", "published_at": "2026-05-15T05:02:27+00:00", "published_display": "15 May 2026 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/dd5031ba-850d-34e0-88ae-fe76c1c7625e/cibus-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-14T22:10:35+00:00", "published_display": "14 May 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/cibus-q1-earnings-snapshot-203707259.html", "source_name": "Associated Press", "published_at": "2026-05-14T20:37:07+00:00", "published_display": "14 May 2026 20:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (CBUS) narrows Q1 2026 loss as cash rises to $30.3M", "summary": "Cibus Inc. reported significantly narrowed net losses for Q1 2026, falling to $21.2 million from $49.4 million year-over-year, while revenue increased to $1.7 million. The company's cash and cash equivalents rose to $30.3 million, supported by two equity offerings, and management", "url": "https://www.stocktitan.net/sec-filings/CBUS/8-k-cibus-inc-reports-material-event-f1777f345507.html", "source_name": "Stock Titan", "published_at": "2026-05-14T20:39:50", "published_display": "14 May 2026 20:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (CBUS) trims Q1 2026 loss but warns on going concern risk", "summary": "Cibus, Inc. (CBUS) reported a narrowed net loss of $21.2 million in Q1 2026, down from $49.4 million a year prior, on increased revenue of $1.7 million. Despite recent equity offerings raising $33.4 million and cost reduction initiatives, the company continues to burn cash and ha", "url": "https://www.stocktitan.net/sec-filings/CBUS/10-q-cibus-inc-quarterly-earnings-report-024adcb498ae.html", "source_name": "Stock Titan", "published_at": "2026-05-14T20:39:00", "published_display": "14 May 2026 20:39", "sentiment": "negative", "sentiment_pct": 31, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gene-edited rice plan: Cibus targets 2027 LATAM launch, $200M", "summary": "Cibus (Nasdaq: CBUS) reported its Q1 2026 financial results, showing a narrowed net loss of $21.2 million, down from $49.4 million a year prior, driven by reduced R&D and SG&A expenses. The company ended the quarter with $30.3 million in cash, expected to fund operations into lat", "url": "https://www.stocktitan.net/news/CBUS/cibus-reports-first-quarter-financial-results-and-provides-business-4a9r1bi1kfor.html", "source_name": "Stock Titan", "published_at": "2026-05-14T19:39:00", "published_display": "14 May 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOT3lTTEFzMzNlZVg4MzlNZ0JfS0xVOTNGZmNZdzZmeFBqcFNvQ0ZKTDNudzJMXzJoWGxwSkJPVUQ1V2lmYmJrQlBBUXJ5bDMyT2IyV1JYYWhLSzVlUm0wLTZWeWU3UkROa3F5SElRczZtT0hSN2pXRjJablBlTWRRUXhLMEZUeTVocTVSWGJXaGIyRmhSdFE?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQNDFjZldKaEF0eEl1c0g5X2xaMHU1c0thenhRM0hZaWtZdzQ3TU0yTzZQZGxyQTYzT2lMakpCT2I3WjBGWFR2M0NwTDhZY0lITmpMVVBON2w4ODhrSkRPMU5ETmt1RExXLXcydWZLb0VmQjlTWTNOWFRkVDJYTFRfdjBvVG9Sd2VMU1VIemZob1pITW9PUkFsZw?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gene-edited rice seed for herbicide tolerance moves into testing", "summary": "Cibus (Nasdaq: CBUS) has transferred gene-edited herbicide-tolerant rice materials to its partner Interoc for testing and production, aiming for a Latin American market launch. This move is a key step in commercializing Cibus's traits developed with its Rapid Trait Development Sy", "url": "https://www.stocktitan.net/news/CBUS/cibus-announces-transfer-of-gene-edited-herbicide-tolerance-traits-ulefrte0j0yl.html", "source_name": "Stock Titan", "published_at": "2026-05-05T00:11:14", "published_display": "05 May 2026 00:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production", "summary": "Cibus, Inc. has announced the transfer of gene-edited herbicide-tolerant rice materials to its partner, Interoc, for testing and production in Latin America. This collaboration aims to launch CIBUS-enhanced seed products, addressing the need for accelerated trait innovation and i", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cibus-announces-transfer-gene-edited-110000639.html", "source_name": "Market source", "published_at": "2026-05-03T17:38:59", "published_display": "03 May 2026 17:38", "sentiment": "positive", "sentiment_pct": 86, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus will discuss Q1 results after market close on May 14", "summary": "Cibus (Nasdaq: CBUS) announced it will report its first quarter 2026 financial results on Thursday, May 14, 2026, after the market close. The company's management team will host a conference call and live audio webcast at 4:30 p.m. ET on the same day to discuss the results and pr", "url": "https://www.stocktitan.net/news/CBUS/cibus-to-report-first-quarter-2026-financial-results-on-may-14-2026-i4hmk1puj2e4.html", "source_name": "Stock Titan", "published_at": "2026-05-01T08:40:10", "published_display": "01 May 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) Sr VP awarded 38,000 shares and 76,000 options", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOMzZxSmdNYTBoMEJjTktLUk5Wbks2WkJnRFFLa0cyNTAwR1B1cDUxRzhtT0xLYzE5Q1VlR0E3Zk1xS2pITFFhYWpEUmdES2xWYTBjYjVRaERYTEkwSE9kanoyb3F4ZklFTEFCWDJJZ2lwMlhDR3Y3YjNlVWE1d2hPSU5xbk1mbXoyWjV2VERiUlhEblRmS1J1MkVkb3lYSVpoWFNqRXpB?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cibus (CBUS) seeks approval of directors, pay and auditor at 2026 virtual meeting", "summary": "Cibus, Inc. is convening its 2026 annual virtual meeting on June 2, 2026, to address key corporate governance matters. Stockholders will vote on the election of nine directors, provide advisory approval for executive compensation, and ratify BDO USA, P.C. as the independent audit", "url": "https://www.stocktitan.net/sec-filings/CBUS/def-14a-cibus-inc-definitive-proxy-statement-e14f74dac1fc.html", "source_name": "Stock Titan", "published_at": "2026-04-20T20:39:44", "published_display": "20 Apr 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus brings in agribusiness veteran Thomas Urban as director", "summary": "Cibus Inc. (Nasdaq: CBUS) has announced the election of Thomas Urban, founder of Agribusiness Advisors, to its Board of Directors. Mr. Urban brings extensive experience in agribusiness scaling, M&A, and executive leadership from his previous roles at CellFor, Pioneer Hi-Bred, and", "url": "https://www.stocktitan.net/news/CBUS/cibus-announces-the-election-of-thomas-urban-to-board-of-shdntocuynjg.html", "source_name": "Stock Titan", "published_at": "2026-04-15T10:39:05", "published_display": "15 Apr 2026 10:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus Announces the Election of Thomas Urban to Board of Directors", "summary": "Cibus, Inc. (Nasdaq: CBUS) has announced the election of Thomas Urban to its Board of Directors. Mr. Urban brings extensive experience in agribusiness, having founded Agribusiness Advisors and previously served as CEO of CellFor, Inc. His expertise is expected to be invaluable as", "url": "https://finance.yahoo.com/markets/stocks/articles/cibus-announces-election-thomas-urban-110000403.html", "source_name": "Market source", "published_at": "2026-04-15T05:10:35", "published_display": "15 Apr 2026 05:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus, Inc. Investigated by the Portnoy Law Firm", "summary": "The Portnoy Law Firm has initiated an investigation into Cibus, Inc. (NASDAQ: CBUS) for possible securities fraud following a 13% stock price drop. This drop was triggered by a Bonitas Research report in June 2024, alleging that Cibus's gene-editing technology lacks market eviden", "url": "https://www.globenewswire.com/news-release/2026/04/08/3270153/0/en/cibus-inc-investigated-by-the-portnoy-law-firm.html", "source_name": "GlobeNewswire", "published_at": "2026-04-08T09:09:50", "published_display": "08 Apr 2026 09:09", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cibus announces underwritten public offering of Class A shares By Investing.com", "summary": "Cibus, Inc. announced its intention to conduct an underwritten public offering of Class A common stock and pre-funded warrants. The agricultural technology company plans to use the net proceeds for working capital and general corporate purposes, including funding the development ", "url": "https://ca.investing.com/news/company-news/cibus-announces-underwritten-public-offering-of-class-a-shares-93CH-4533095", "source_name": "Investing.com Canada", "published_at": "2026-03-27T20:39:44", "published_display": "27 Mar 2026 20:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) sells 6.98M Class A shares at $2.15 each", "summary": "Cibus, Inc. is offering 6,976,744 shares of Class A Common Stock at $2.15 per share, with an underwriter option for an additional 1,046,511 shares. The company expects to net approximately $13.5 million (or $16.0 million if the option is fully exercised) and will use the proceeds", "url": "https://www.stocktitan.net/sec-filings/CBUS/424b5-cibus-inc-prospectus-supplement-debt-securities-0a359c7a20a5.html", "source_name": "Stock Titan", "published_at": "2026-03-26T21:09:14", "published_display": "26 Mar 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus, Inc. Announces Pricing of Public Offering of Class A Common Stock", "summary": "Cibus, Inc. announced the pricing of a public offering of 6,976,744 shares of its Class A Common Stock at $2.15 per share, aiming to raise approximately $15 million. The company has also granted the underwriter an option to purchase an additional 1,046,511 shares. The net proceed", "url": "https://finance.yahoo.com/markets/stocks/articles/cibus-inc-announces-pricing-public-105500198.html", "source_name": "Market source", "published_at": "2026-03-26T03:55:00", "published_display": "26 Mar 2026 03:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) seeks capital via Class A shares and pre-funded warrants", "summary": "Cibus, Inc. is offering Class A Common Stock and pre-funded warrants through a firm commitment underwritten basis to raise capital. The company, facing substantial doubt about its ability to continue as a going concern with $9.9 million cash versus $16.9 million current liabiliti", "url": "https://www.stocktitan.net/sec-filings/CBUS/424b5-cibus-inc-prospectus-supplement-debt-securities-83e7422e0778.html", "source_name": "Stock Titan", "published_at": "2026-03-25T20:39:28", "published_display": "25 Mar 2026 20:39", "sentiment": "negative", "sentiment_pct": 37, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants", "summary": "Cibus, Inc. (Nasdaq: CBUS) has announced its intention to offer shares of Class A common stock and pre-funded warrants in an underwritten public offering. The company also plans to grant the underwriter a 30-day option to purchase additional shares. Proceeds from the offering wil", "url": "https://sg.finance.yahoo.com/news/cibus-inc-announces-proposed-public-200100256.html", "source_name": "Market source", "published_at": "2026-03-25T19:39:28", "published_display": "25 Mar 2026 19:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus seeks new capital for rice weed-trait work through stock sale", "summary": "Cibus (Nasdaq: CBUS) announced a proposed underwritten public offering of Class A common stock and pre-funded warrants to raise capital for working capital and to fund the development of weed management traits in rice. The offering, which will be conducted under an effective Form", "url": "https://www.stocktitan.net/news/CBUS/cibus-inc-announces-proposed-public-offering-of-class-a-common-stock-r5grvc97fukf.html", "source_name": "Stock Titan", "published_at": "2026-03-25T19:39:28", "published_display": "25 Mar 2026 19:39", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus sells nearly 7M shares to fund rice weed-trait development", "summary": "Cibus (Nasdaq: CBUS) has priced an underwritten public offering of 6,976,744 Class A shares at $2.15 per share, aiming to raise approximately $15 million in gross proceeds. The company intends to use the net proceeds for working capital and to further develop its weed management ", "url": "https://www.stocktitan.net/news/CBUS/cibus-inc-announces-pricing-of-public-offering-of-class-a-common-orhrbiznxd84.html", "source_name": "Stock Titan", "published_at": "2026-03-24T22:10:35", "published_display": "24 Mar 2026 22:10", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) doubles down on gene-edited rice traits amid funding risk", "summary": "Cibus, an agricultural biotechnology company, is intensifying its focus on gene-edited rice traits and sustainable ingredients, particularly herbicide-tolerant rice, amid ongoing funding risks. The company has streamlined operations through workforce reductions and facility conso", "url": "https://www.stocktitan.net/sec-filings/CBUS/10-k-cibus-inc-files-annual-report-41c684c0a2ee.html", "source_name": "Stock Titan", "published_at": "2026-03-17T20:09:37", "published_display": "17 Mar 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gene-edited rice, $200M royalties: inside Cibus' 2027 push", "summary": "Cibus (Nasdaq: CBUS) reported its Q4 2025 financial results, highlighting progress in its gene-edited Rice program with targeted commercial launches in LATAM by 2027 and the USA by 2028, potentially generating over $200 million in annual royalties. The company also announced a fi", "url": "https://www.stocktitan.net/news/CBUS/cibus-reports-fourth-quarter-financial-results-and-provides-business-yuguqb07ntwk.html", "source_name": "Stock Titan", "published_at": "2026-03-17T20:09:37", "published_display": "17 Mar 2026 20:09", "sentiment": "negative", "sentiment_pct": 32, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) posts wider Q4 loss and sees cash runway into Q3 2026", "summary": "Cibus, Inc. reported a wider Q4 2025 net loss of $31.9 million, driven by a $9.1 million asset impairment, despite revenue of $1.1 million and efforts to reduce operating expenses. The company's cash and cash equivalents, including recent public offering proceeds, are expected to", "url": "https://www.stocktitan.net/sec-filings/CBUS/8-k-cibus-inc-reports-material-event-4f41aed22e1b.html", "source_name": "Stock Titan", "published_at": "2026-03-17T20:09:37", "published_display": "17 Mar 2026 20:09", "sentiment": "negative", "sentiment_pct": 26, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CIBUS ($CBUS) Releases Q4 2025 Earnings | CBUS Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOQ0gxVm40dEs5a01tcm03bFdCUndoWVRmSE1TMHFkb1N0bHVoYTlhdThycVo0ZlQzeU5vN3I5dV9fbWwyREVfbmFiR2xFZ2ZOcnBHMFVVM1RBWnJqVm54SEMyZG4yaUVFVy02dnQ2bk5FM3hPQm5qQlduZFluWGZOT2pFcHg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CBUS Stock Price and Chart \u2014 NASDAQ:CBUS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9td3g5UFZBbEdqZjRNQVJOMFNMazhaYmRvQ2lmaUxtNlQ0YXNGMzVWQ0ltanEyd296YTRmdXNWUmtuMXM4dFp0TFBFbXFNNnBwdlRZbC1lNHpUeGFh?oc=5", "source_name": "TradingView", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus to detail 2025 results in March 17 earnings call event", "summary": "Cibus (Nasdaq: CBUS) announced it will report its fourth quarter 2025 financial results on March 17, 2026, after the market closes. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide company updates. The article also touches on t", "url": "https://www.stocktitan.net/news/CBUS/cibus-to-report-fourth-quarter-2025-financial-results-on-march-17-0zlec2b9rsky.html", "source_name": "Stock Titan", "published_at": "2026-03-01T07:40:03", "published_display": "01 Mar 2026 07:40", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus Partnering with The John Innes Centre for UK Government\u2019s Farming Innovation Programme Precision Breeding Initiative", "summary": "Cibus (Nasdaq: CBUS) has joined the UK Government-funded LLS-ERASED precision breeding project, collaborating with the John Innes Centre and other partners. The initiative aims to develop durable resistance to Light Leaf Spot in oilseed rape, a disease that caused an estimated \u00a33", "url": "https://www.stocktitan.net/news/CBUS/cibus-partnering-with-the-john-innes-centre-for-uk-government-s-abxyxtvk1hn2.html", "source_name": "Stock Titan", "published_at": "2026-02-06T12:02:36", "published_display": "06 Feb 2026 12:02", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus directors eye stock in planned sale to fund rice weed traits", "summary": "Cibus (Nasdaq: CBUS) announced a proposed underwritten public offering of its Class A common stock to fund working capital, develop rice weed-management traits, and cover professional expenses. BTIG, LLC is the sole underwriter, with an option to purchase up to 15% additional sha", "url": "https://www.stocktitan.net/news/CBUS/cibus-inc-announces-proposed-public-offering-of-class-a-common-h3ryzx79879r.html", "source_name": "Stock Titan", "published_at": "2026-01-29T14:32:22", "published_display": "29 Jan 2026 14:32", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus board joins $20M share sale, backing rice weed trait R&D", "summary": "Cibus, Inc. announced the pricing of a $20.0 million public offering of 13,333,333 shares of Class A common stock at $1.50 per share. Members of Cibus' Board of Directors have committed to purchase 1,000,000 shares in the offering. The net proceeds are intended for working capita", "url": "https://www.stocktitan.net/news/CBUS/cibus-inc-announces-pricing-of-20-0-million-public-offering-of-class-ucnumeu0dz3v.html", "source_name": "Stock Titan", "published_at": "2026-01-29T11:59:16", "published_display": "29 Jan 2026 11:59", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus' Agri-Bio Gamble - Technology Is Promising, Cash Is Limited, Execution Is Key", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPZFZKWjlPU3V0S0tfeGV2d3h5NmVaVnRxN1lKa3JTcGVEQzEwOXFnNmctYWlndTd3cDctd2pNbVZZWU9qbHlfMHhKU3BzSmpaYks5SjNqY2ZOQjFObmRRNnFsUWVoUGNMTl9tbmpxdFZMb1NPWmVvZ2NYZDgxMkdlMXk5Q05MOHo5WnFUTmtpVG5pNXllUXpQSVh6LUJmYmhuMmIxUEFXM3ZtamQ5NlQxVm9pZkI2RUFsYmxJ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-13T08:00:00+00:00", "published_display": "13 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Retail investors invested in Cibus, Inc. (NASDAQ:CBUS) up 11% last week, insiders too were rewarded", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-04T08:00:00+00:00", "published_display": "04 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Gene-Edited Alfalfa Gets FDA Green Light: Cibus Ready for Commercial Launch", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQjFQcjlmZmNmUjNWVFZEcjItaEJNeUZOTzAxYTV3SFFoVVNpS0lVVmZJTTFRdkt4NUMzcEsybTVLcG12UFlxSmdfWk9uQzBEWDBIRWRlUDFkdi1TaFVNVl9STTlfTllsRW5mTzVhS3RQZnFyeVQtSndFR1E4bzdMb1lKMlY1UFl3QU1pWTFUTHFuWkVoUjNWaDJiZjVrRERURkhLSVU4cHlONDF4b1JraDhqU1hsNF9a?oc=5", "source_name": "Stock Titan", "published_at": "2025-06-24T07:00:00+00:00", "published_display": "24 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Calyxt Announces Stockholder Approval of Merger With Cibus", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPM1lSYjd5dlhRUGN4UkxURXR3TUl0dGVLV3FGekVtelh0Z3cwWVFfWkJlMTJ2dnczejBqbjBkS012cmhFaV8xU0J6X3NfWUZtVXRCdWdMZjdqSk0ycEd2MFM2SFVLd1lteUxJSzE5YXVmR241eER5QUhTWXhnbG1OYTdDZ0RoTlFvelJGMEtfajlVOUQyQ1FqX3NzQzlOTGdPSUpIZEF1WkV4d3E5YU5RbzVLdjc?oc=5", "source_name": "PR Newswire", "published_at": "2023-05-19T07:00:00+00:00", "published_display": "19 May 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Cibus (CBUS) Welcomes Landmark EU Crop Breeding Decision", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cibus-cbus-welcomes-landmark-eu-103305040.html", "source_name": "Insider Monkey", "published_at": "2026-07-14T10:33:05+00:00", "published_display": "14 Jul 2026 10:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/europe-recognizes-nature-based-plant-120500250.html", "source_name": "GlobeNewswire", "published_at": "2026-06-17T12:05:00+00:00", "published_display": "17 Jun 2026 12:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Europe opens fast lane for non-GMO crops; Cibus traits expected to fit", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPR1dZc1A1M0RJalJmTU5tVTB5Z3hNbG4tTXhBTXNlV2NFMTZCY09EMGdiOGRkdl84YWV0S1dYYnJDYUhNZ01FQWZGZVlvQlVVUEloWDh4SktmQXJRY3V1a0ZIWGp4eTMxX1lqV0d3RU82X2J6Q2xjcVppMEdSSWtMdUplRy1WUXJuT0Z2Qi00YTloYWFSUnpyaXZmaHBvdlBZMk9vS3BDdW5kd1FPakZtYWx2YmtQVm1q?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) taps Farmland LP founder Craig Wichner as CEO", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNTXd1TG1xaFZSTjZaa0M5dEhvMlpaSjhmLTg4bm5hRWVsTE1tWnJfaXh2eE9tVzlqS0xoM2ZVaWJUeWs1cVVTSDZjSndqNnhWelZEQWZRd3R3QnZxZnBOTXdCWUdFSEZ6OEVlLXZ2cFREVGxFTzJ3UDExWldpUEV4VHZhSWRYcnlkUEdKZ0p4SHlDWndCb1Q3ZWxJZVQ2UzA?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cibus-names-agricultural-biotechnology-leader-223000039.html", "source_name": "GlobeNewswire", "published_at": "2026-06-08T22:30:00+00:00", "published_display": "08 Jun 2026 22:30", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Farmland investor Craig Wichner becomes Cibus CEO, targets commercialization", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOc3hBX25ucXE4QzZSSVdWQW1XQ01tSmV3NmVRZ05md2xwVmNPVjgwdS1Da1NPLW84MlQyX2dyZjlyWmRueGNGYUtJSzlTMVBOb243NWRDLVlkaU1HM2l6RHM0OXhnYzFBQ2g4Qmo4V0xqRVYxVk9MT3dEUVFmRlRlMndsdGtMdWpnQk0zTy05dWVBLTNYQlk1Y2hLWTdIU1E3b0dndEdna1F2VnpDaUxCd2g1T09Vd2U1eEFjVkVDNUY?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus appoints Craig Wichner as chief executive officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPSDZMUTc2V1Y1X2FqTWF5UXZzajFDOUp5SjJrYTNZSDJBUlJWNXY1Uk0tRVZxT0FqTlQyT0x6eTdNcEw3Rzh6QXpCYUtaNTJzMWw3TWJ6eEJ2SlhXSUVVUFlhaWZoNFhtN3lLNHdoSHRScjZFNzltRlJhdjNRNmpPYjlaT2ttOXBJVHVUVm1MVnRqSlV1aERWem1UbDl6U3pPOHZ1QWQ5bmpvT0N2b1Y5MEt3?oc=5", "source_name": "Investing.com", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (CBUS) 2026 meeting backs board slate, executive pay and BDO", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQWGlieEhDWVpyUVFSSmpLTlhrUmVXV3NzUkpTTF93MGdLMC11QjZwQXdDUl82MHhPNndOTi1Sc3ZqQ3dCMEZxZkFDMUFOODNDTGhaRkxCUlhRRS14ZU53LVZoZ0RadmdIeTJtRGlpOEFUUWd1Qk41aFpFVXg1NzVackNmSUhMcjdIVWRYcEdQYnhjMUE4bWhLUEZjSElySE0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[EFFECT] Cibus, Inc. SEC Filing", "summary": "This article announces an SEC filing by Cibus, Inc. (CBUS) for a Form EFFECT, which is a Type S-3 Shelf Registration Statement. The filing has a neutral impact and sentiment and its effectiveness date was May 22, 2026, at 4:00 P.M. The article also provides recent news and other ", "url": "https://www.stocktitan.net/sec-filings/CBUS/effect-cibus-inc-sec-filing-468c179c9750.html", "source_name": "Stock Titan", "published_at": "2026-05-27T07:40:30", "published_display": "27 May 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) files at\u2011the\u2011market $50M shelf with Jefferies", "summary": "Cibus (NASDAQ: CBUS) has filed an at-the-market (ATM) shelf prospectus to offer and sell up to $50 million of its Class A Common Stock through Jefferies LLC. The company plans to use the net proceeds for working capital and general corporate purposes, including the further develo", "url": "https://www.stocktitan.net/sec-filings/CBUS/424b2-cibus-inc-prospectus-supplement-8c8042db9781.html", "source_name": "Stock Titan", "published_at": "2026-05-23T19:09:51", "published_display": "23 May 2026 19:09", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (CBUS) registers 10.74M shares issuable on warrants \u2014 issuer to receive proceeds", "summary": "Cibus, Inc. (CBUS) has registered 10,738,040 shares of Class A Common Stock obtainable through the exercise of existing warrants. The company expects to receive approximately $26.6 million in proceeds if all warrants are fully exercised, which will be allocated towards working ca", "url": "https://www.stocktitan.net/sec-filings/CBUS/424b3-cibus-inc-prospectus-filed-pursuant-to-rule-424-b-3-65562dcff148.html", "source_name": "Stock Titan", "published_at": "2026-05-23T05:40:11", "published_display": "23 May 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus Reports First Quarter Financial Results and Provides Business Update", "summary": "Cibus, Inc. announced its financial results for the first quarter ended March 31, 2026, highlighting continued momentum in its Rice herbicide tolerance and Sustainable Ingredients programs. The company reported a reduced net loss of $21.2 million compared to $49.4 million in the ", "url": "https://sg.finance.yahoo.com/news/cibus-reports-first-quarter-financial-200500136.html", "source_name": "Market source", "published_at": "2026-05-15T14:09:40", "published_display": "15 May 2026 14:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/90e7be81-b482-3d6f-acc0-2680e3086f1b/cibus%2C-inc.-q1-2026-earnings.html", "source_name": "Moby", "published_at": "2026-05-15T12:30:00+00:00", "published_display": "15 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus Inc (CBUS) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/cibus-inc-cbus-q1-2026-050227266.html", "source_name": "GuruFocus.com", "published_at": "2026-05-15T05:02:27+00:00", "published_display": "15 May 2026 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/dd5031ba-850d-34e0-88ae-fe76c1c7625e/cibus-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-14T22:10:35+00:00", "published_display": "14 May 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/cibus-q1-earnings-snapshot-203707259.html", "source_name": "Associated Press", "published_at": "2026-05-14T20:37:07+00:00", "published_display": "14 May 2026 20:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (CBUS) narrows Q1 2026 loss as cash rises to $30.3M", "summary": "Cibus Inc. reported significantly narrowed net losses for Q1 2026, falling to $21.2 million from $49.4 million year-over-year, while revenue increased to $1.7 million. The company's cash and cash equivalents rose to $30.3 million, supported by two equity offerings, and management", "url": "https://www.stocktitan.net/sec-filings/CBUS/8-k-cibus-inc-reports-material-event-f1777f345507.html", "source_name": "Stock Titan", "published_at": "2026-05-14T20:39:50", "published_display": "14 May 2026 20:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (CBUS) trims Q1 2026 loss but warns on going concern risk", "summary": "Cibus, Inc. (CBUS) reported a narrowed net loss of $21.2 million in Q1 2026, down from $49.4 million a year prior, on increased revenue of $1.7 million. Despite recent equity offerings raising $33.4 million and cost reduction initiatives, the company continues to burn cash and ha", "url": "https://www.stocktitan.net/sec-filings/CBUS/10-q-cibus-inc-quarterly-earnings-report-024adcb498ae.html", "source_name": "Stock Titan", "published_at": "2026-05-14T20:39:00", "published_display": "14 May 2026 20:39", "sentiment": "negative", "sentiment_pct": 31, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gene-edited rice plan: Cibus targets 2027 LATAM launch, $200M", "summary": "Cibus (Nasdaq: CBUS) reported its Q1 2026 financial results, showing a narrowed net loss of $21.2 million, down from $49.4 million a year prior, driven by reduced R&D and SG&A expenses. The company ended the quarter with $30.3 million in cash, expected to fund operations into lat", "url": "https://www.stocktitan.net/news/CBUS/cibus-reports-first-quarter-financial-results-and-provides-business-4a9r1bi1kfor.html", "source_name": "Stock Titan", "published_at": "2026-05-14T19:39:00", "published_display": "14 May 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOT3lTTEFzMzNlZVg4MzlNZ0JfS0xVOTNGZmNZdzZmeFBqcFNvQ0ZKTDNudzJMXzJoWGxwSkJPVUQ1V2lmYmJrQlBBUXJ5bDMyT2IyV1JYYWhLSzVlUm0wLTZWeWU3UkROa3F5SElRczZtT0hSN2pXRjJablBlTWRRUXhLMEZUeTVocTVSWGJXaGIyRmhSdFE?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQNDFjZldKaEF0eEl1c0g5X2xaMHU1c0thenhRM0hZaWtZdzQ3TU0yTzZQZGxyQTYzT2lMakpCT2I3WjBGWFR2M0NwTDhZY0lITmpMVVBON2w4ODhrSkRPMU5ETmt1RExXLXcydWZLb0VmQjlTWTNOWFRkVDJYTFRfdjBvVG9Sd2VMU1VIemZob1pITW9PUkFsZw?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gene-edited rice seed for herbicide tolerance moves into testing", "summary": "Cibus (Nasdaq: CBUS) has transferred gene-edited herbicide-tolerant rice materials to its partner Interoc for testing and production, aiming for a Latin American market launch. This move is a key step in commercializing Cibus's traits developed with its Rapid Trait Development Sy", "url": "https://www.stocktitan.net/news/CBUS/cibus-announces-transfer-of-gene-edited-herbicide-tolerance-traits-ulefrte0j0yl.html", "source_name": "Stock Titan", "published_at": "2026-05-05T00:11:14", "published_display": "05 May 2026 00:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production", "summary": "Cibus, Inc. has announced the transfer of gene-edited herbicide-tolerant rice materials to its partner, Interoc, for testing and production in Latin America. This collaboration aims to launch CIBUS-enhanced seed products, addressing the need for accelerated trait innovation and i", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cibus-announces-transfer-gene-edited-110000639.html", "source_name": "Market source", "published_at": "2026-05-03T17:38:59", "published_display": "03 May 2026 17:38", "sentiment": "positive", "sentiment_pct": 86, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus will discuss Q1 results after market close on May 14", "summary": "Cibus (Nasdaq: CBUS) announced it will report its first quarter 2026 financial results on Thursday, May 14, 2026, after the market close. The company's management team will host a conference call and live audio webcast at 4:30 p.m. ET on the same day to discuss the results and pr", "url": "https://www.stocktitan.net/news/CBUS/cibus-to-report-first-quarter-2026-financial-results-on-may-14-2026-i4hmk1puj2e4.html", "source_name": "Stock Titan", "published_at": "2026-05-01T08:40:10", "published_display": "01 May 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) Sr VP awarded 38,000 shares and 76,000 options", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOMzZxSmdNYTBoMEJjTktLUk5Wbks2WkJnRFFLa0cyNTAwR1B1cDUxRzhtT0xLYzE5Q1VlR0E3Zk1xS2pITFFhYWpEUmdES2xWYTBjYjVRaERYTEkwSE9kanoyb3F4ZklFTEFCWDJJZ2lwMlhDR3Y3YjNlVWE1d2hPSU5xbk1mbXoyWjV2VERiUlhEblRmS1J1MkVkb3lYSVpoWFNqRXpB?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (CBUS) seeks approval of directors, pay and auditor at 2026 virtual meeting", "summary": "Cibus, Inc. is convening its 2026 annual virtual meeting on June 2, 2026, to address key corporate governance matters. Stockholders will vote on the election of nine directors, provide advisory approval for executive compensation, and ratify BDO USA, P.C. as the independent audit", "url": "https://www.stocktitan.net/sec-filings/CBUS/def-14a-cibus-inc-definitive-proxy-statement-e14f74dac1fc.html", "source_name": "Stock Titan", "published_at": "2026-04-20T20:39:44", "published_display": "20 Apr 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus brings in agribusiness veteran Thomas Urban as director", "summary": "Cibus Inc. (Nasdaq: CBUS) has announced the election of Thomas Urban, founder of Agribusiness Advisors, to its Board of Directors. Mr. Urban brings extensive experience in agribusiness scaling, M&A, and executive leadership from his previous roles at CellFor, Pioneer Hi-Bred, and", "url": "https://www.stocktitan.net/news/CBUS/cibus-announces-the-election-of-thomas-urban-to-board-of-shdntocuynjg.html", "source_name": "Stock Titan", "published_at": "2026-04-15T10:39:05", "published_display": "15 Apr 2026 10:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus Announces the Election of Thomas Urban to Board of Directors", "summary": "Cibus, Inc. (Nasdaq: CBUS) has announced the election of Thomas Urban to its Board of Directors. Mr. Urban brings extensive experience in agribusiness, having founded Agribusiness Advisors and previously served as CEO of CellFor, Inc. His expertise is expected to be invaluable as", "url": "https://finance.yahoo.com/markets/stocks/articles/cibus-announces-election-thomas-urban-110000403.html", "source_name": "Market source", "published_at": "2026-04-15T05:10:35", "published_display": "15 Apr 2026 05:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus, Inc. Investigated by the Portnoy Law Firm", "summary": "The Portnoy Law Firm has initiated an investigation into Cibus, Inc. (NASDAQ: CBUS) for possible securities fraud following a 13% stock price drop. This drop was triggered by a Bonitas Research report in June 2024, alleging that Cibus's gene-editing technology lacks market eviden", "url": "https://www.globenewswire.com/news-release/2026/04/08/3270153/0/en/cibus-inc-investigated-by-the-portnoy-law-firm.html", "source_name": "GlobeNewswire", "published_at": "2026-04-08T09:09:50", "published_display": "08 Apr 2026 09:09", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus announces underwritten public offering of Class A shares By Investing.com", "summary": "Cibus, Inc. announced its intention to conduct an underwritten public offering of Class A common stock and pre-funded warrants. The agricultural technology company plans to use the net proceeds for working capital and general corporate purposes, including funding the development ", "url": "https://ca.investing.com/news/company-news/cibus-announces-underwritten-public-offering-of-class-a-shares-93CH-4533095", "source_name": "Investing.com Canada", "published_at": "2026-03-27T20:39:44", "published_display": "27 Mar 2026 20:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) sells 6.98M Class A shares at $2.15 each", "summary": "Cibus, Inc. is offering 6,976,744 shares of Class A Common Stock at $2.15 per share, with an underwriter option for an additional 1,046,511 shares. The company expects to net approximately $13.5 million (or $16.0 million if the option is fully exercised) and will use the proceeds", "url": "https://www.stocktitan.net/sec-filings/CBUS/424b5-cibus-inc-prospectus-supplement-debt-securities-0a359c7a20a5.html", "source_name": "Stock Titan", "published_at": "2026-03-26T21:09:14", "published_display": "26 Mar 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus, Inc. Announces Pricing of Public Offering of Class A Common Stock", "summary": "Cibus, Inc. announced the pricing of a public offering of 6,976,744 shares of its Class A Common Stock at $2.15 per share, aiming to raise approximately $15 million. The company has also granted the underwriter an option to purchase an additional 1,046,511 shares. The net proceed", "url": "https://finance.yahoo.com/markets/stocks/articles/cibus-inc-announces-pricing-public-105500198.html", "source_name": "Market source", "published_at": "2026-03-26T03:55:00", "published_display": "26 Mar 2026 03:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) seeks capital via Class A shares and pre-funded warrants", "summary": "Cibus, Inc. is offering Class A Common Stock and pre-funded warrants through a firm commitment underwritten basis to raise capital. The company, facing substantial doubt about its ability to continue as a going concern with $9.9 million cash versus $16.9 million current liabiliti", "url": "https://www.stocktitan.net/sec-filings/CBUS/424b5-cibus-inc-prospectus-supplement-debt-securities-83e7422e0778.html", "source_name": "Stock Titan", "published_at": "2026-03-25T20:39:28", "published_display": "25 Mar 2026 20:39", "sentiment": "negative", "sentiment_pct": 37, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock and Pre-Funded Warrants", "summary": "Cibus, Inc. (Nasdaq: CBUS) has announced its intention to offer shares of Class A common stock and pre-funded warrants in an underwritten public offering. The company also plans to grant the underwriter a 30-day option to purchase additional shares. Proceeds from the offering wil", "url": "https://sg.finance.yahoo.com/news/cibus-inc-announces-proposed-public-200100256.html", "source_name": "Market source", "published_at": "2026-03-25T19:39:28", "published_display": "25 Mar 2026 19:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus seeks new capital for rice weed-trait work through stock sale", "summary": "Cibus (Nasdaq: CBUS) announced a proposed underwritten public offering of Class A common stock and pre-funded warrants to raise capital for working capital and to fund the development of weed management traits in rice. The offering, which will be conducted under an effective Form", "url": "https://www.stocktitan.net/news/CBUS/cibus-inc-announces-proposed-public-offering-of-class-a-common-stock-r5grvc97fukf.html", "source_name": "Stock Titan", "published_at": "2026-03-25T19:39:28", "published_display": "25 Mar 2026 19:39", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus sells nearly 7M shares to fund rice weed-trait development", "summary": "Cibus (Nasdaq: CBUS) has priced an underwritten public offering of 6,976,744 Class A shares at $2.15 per share, aiming to raise approximately $15 million in gross proceeds. The company intends to use the net proceeds for working capital and to further develop its weed management ", "url": "https://www.stocktitan.net/news/CBUS/cibus-inc-announces-pricing-of-public-offering-of-class-a-common-orhrbiznxd84.html", "source_name": "Stock Titan", "published_at": "2026-03-24T22:10:35", "published_display": "24 Mar 2026 22:10", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) doubles down on gene-edited rice traits amid funding risk", "summary": "Cibus, an agricultural biotechnology company, is intensifying its focus on gene-edited rice traits and sustainable ingredients, particularly herbicide-tolerant rice, amid ongoing funding risks. The company has streamlined operations through workforce reductions and facility conso", "url": "https://www.stocktitan.net/sec-filings/CBUS/10-k-cibus-inc-files-annual-report-41c684c0a2ee.html", "source_name": "Stock Titan", "published_at": "2026-03-17T20:09:37", "published_display": "17 Mar 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gene-edited rice, $200M royalties: inside Cibus' 2027 push", "summary": "Cibus (Nasdaq: CBUS) reported its Q4 2025 financial results, highlighting progress in its gene-edited Rice program with targeted commercial launches in LATAM by 2027 and the USA by 2028, potentially generating over $200 million in annual royalties. The company also announced a fi", "url": "https://www.stocktitan.net/news/CBUS/cibus-reports-fourth-quarter-financial-results-and-provides-business-yuguqb07ntwk.html", "source_name": "Stock Titan", "published_at": "2026-03-17T20:09:37", "published_display": "17 Mar 2026 20:09", "sentiment": "negative", "sentiment_pct": 32, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus (NASDAQ: CBUS) posts wider Q4 loss and sees cash runway into Q3 2026", "summary": "Cibus, Inc. reported a wider Q4 2025 net loss of $31.9 million, driven by a $9.1 million asset impairment, despite revenue of $1.1 million and efforts to reduce operating expenses. The company's cash and cash equivalents, including recent public offering proceeds, are expected to", "url": "https://www.stocktitan.net/sec-filings/CBUS/8-k-cibus-inc-reports-material-event-4f41aed22e1b.html", "source_name": "Stock Titan", "published_at": "2026-03-17T20:09:37", "published_display": "17 Mar 2026 20:09", "sentiment": "negative", "sentiment_pct": 26, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CIBUS ($CBUS) Releases Q4 2025 Earnings | CBUS Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOQ0gxVm40dEs5a01tcm03bFdCUndoWVRmSE1TMHFkb1N0bHVoYTlhdThycVo0ZlQzeU5vN3I5dV9fbWwyREVfbmFiR2xFZ2ZOcnBHMFVVM1RBWnJqVm54SEMyZG4yaUVFVy02dnQ2bk5FM3hPQm5qQlduZFluWGZOT2pFcHg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CBUS Stock Price and Chart \u2014 NASDAQ:CBUS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9td3g5UFZBbEdqZjRNQVJOMFNMazhaYmRvQ2lmaUxtNlQ0YXNGMzVWQ0ltanEyd296YTRmdXNWUmtuMXM4dFp0TFBFbXFNNnBwdlRZbC1lNHpUeGFh?oc=5", "source_name": "TradingView", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus to detail 2025 results in March 17 earnings call event", "summary": "Cibus (Nasdaq: CBUS) announced it will report its fourth quarter 2025 financial results on March 17, 2026, after the market closes. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide company updates. The article also touches on t", "url": "https://www.stocktitan.net/news/CBUS/cibus-to-report-fourth-quarter-2025-financial-results-on-march-17-0zlec2b9rsky.html", "source_name": "Stock Titan", "published_at": "2026-03-01T07:40:03", "published_display": "01 Mar 2026 07:40", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus Partnering with The John Innes Centre for UK Government\u2019s Farming Innovation Programme Precision Breeding Initiative", "summary": "Cibus (Nasdaq: CBUS) has joined the UK Government-funded LLS-ERASED precision breeding project, collaborating with the John Innes Centre and other partners. The initiative aims to develop durable resistance to Light Leaf Spot in oilseed rape, a disease that caused an estimated \u00a33", "url": "https://www.stocktitan.net/news/CBUS/cibus-partnering-with-the-john-innes-centre-for-uk-government-s-abxyxtvk1hn2.html", "source_name": "Stock Titan", "published_at": "2026-02-06T12:02:36", "published_display": "06 Feb 2026 12:02", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus directors eye stock in planned sale to fund rice weed traits", "summary": "Cibus (Nasdaq: CBUS) announced a proposed underwritten public offering of its Class A common stock to fund working capital, develop rice weed-management traits, and cover professional expenses. BTIG, LLC is the sole underwriter, with an option to purchase up to 15% additional sha", "url": "https://www.stocktitan.net/news/CBUS/cibus-inc-announces-proposed-public-offering-of-class-a-common-h3ryzx79879r.html", "source_name": "Stock Titan", "published_at": "2026-01-29T14:32:22", "published_display": "29 Jan 2026 14:32", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus board joins $20M share sale, backing rice weed trait R&D", "summary": "Cibus, Inc. announced the pricing of a $20.0 million public offering of 13,333,333 shares of Class A common stock at $1.50 per share. Members of Cibus' Board of Directors have committed to purchase 1,000,000 shares in the offering. The net proceeds are intended for working capita", "url": "https://www.stocktitan.net/news/CBUS/cibus-inc-announces-pricing-of-20-0-million-public-offering-of-class-ucnumeu0dz3v.html", "source_name": "Stock Titan", "published_at": "2026-01-29T11:59:16", "published_display": "29 Jan 2026 11:59", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cibus' Agri-Bio Gamble - Technology Is Promising, Cash Is Limited, Execution Is Key", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPZFZKWjlPU3V0S0tfeGV2d3h5NmVaVnRxN1lKa3JTcGVEQzEwOXFnNmctYWlndTd3cDctd2pNbVZZWU9qbHlfMHhKU3BzSmpaYks5SjNqY2ZOQjFObmRRNnFsUWVoUGNMTl9tbmpxdFZMb1NPWmVvZ2NYZDgxMkdlMXk5Q05MOHo5WnFUTmtpVG5pNXllUXpQSVh6LUJmYmhuMmIxUEFXM3ZtamQ5NlQxVm9pZkI2RUFsYmxJ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-13T08:00:00+00:00", "published_display": "13 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Retail investors invested in Cibus, Inc. (NASDAQ:CBUS) up 11% last week, insiders too were rewarded", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNYkl3TVJoUW9WY0xmallBVzFDZVNla09JVF9QMXhhYjE3UG1hM1BvYl93MEdiYmtTalBoc1Z6WFpEM2VfSUxEODM3Z1RmeUJ2X0otWGpWMnRRLUd1VDFINWRmX2UxbVl1Wm5LeVJ6LS1aRnR2VFkzM3dfSkJDTGJfTzJtOUxJMmFnS0tCNGFyczlfUEtYeDZHSEt0Qk5jMzNvQUdrckotNHo1ZFZTNTZILUhtdEI3WlJ5ajNYMWRzZnF2cExjMmZrVXlsY0JNbzZ2bW5PQm9R0gHbAUFVX3lxTFAyRzFDQkFvSXIybER3OUZUSHYtMHkxeXk3WUtfTWdHS3ZnaVVuTG9GTGRsajFoVHZRWGlfLUEzdFNDQmN5TERKQVlhV3daTTJoUFZsWVVnMi1ZZ0JydGZYVkV0ZDFIV0lVQW9Cb2lTeXZEVkV4dnV0by1FVlhHTVJDSURzREpxaDNnV3lzUTU3SElZY3E1MmNYd3Mtc3NOQXp1Vlg3UzNoaXhWOTNjOUFKdEtkMG91NndLUEl4TG5lU19qUkFlVGdhNXpsczA2ektpZV9PMm81eGxDbw?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-04T08:00:00+00:00", "published_display": "04 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First Gene-Edited Alfalfa Gets FDA Green Light: Cibus Ready for Commercial Launch", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQjFQcjlmZmNmUjNWVFZEcjItaEJNeUZOTzAxYTV3SFFoVVNpS0lVVmZJTTFRdkt4NUMzcEsybTVLcG12UFlxSmdfWk9uQzBEWDBIRWRlUDFkdi1TaFVNVl9STTlfTllsRW5mTzVhS3RQZnFyeVQtSndFR1E4bzdMb1lKMlY1UFl3QU1pWTFUTHFuWkVoUjNWaDJiZjVrRERURkhLSVU4cHlONDF4b1JraDhqU1hsNF9a?oc=5", "source_name": "Stock Titan", "published_at": "2025-06-24T07:00:00+00:00", "published_display": "24 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Calyxt Announces Stockholder Approval of Merger With Cibus", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPM1lSYjd5dlhRUGN4UkxURXR3TUl0dGVLV3FGekVtelh0Z3cwWVFfWkJlMTJ2dnczejBqbjBkS012cmhFaV8xU0J6X3NfWUZtVXRCdWdMZjdqSk0ycEd2MFM2SFVLd1lteUxJSzE5YXVmR241eER5QUhTWXhnbG1OYTdDZ0RoTlFvelJGMEtfajlVOUQyQ1FqX3NzQzlOTGdPSUpIZEF1WkV4d3E5YU5RbzVLdjc?oc=5", "source_name": "PR Newswire", "published_at": "2023-05-19T07:00:00+00:00", "published_display": "19 May 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 91, "total_relevant": 57, "sentiment_summary": {"positive": 10, "negative": 14, "neutral": 33, "score": 49, "total": 57, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 14.85, "count": 27}, {"event": "earnings", "label": "Earnings", "weight": 10.8, "count": 21}, {"event": "liquidity", "label": "Balance sheet", "weight": 2.0, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 14}, "market_context": {"has_market_context": true, "latest_close": 2.02, "latest_week": "2026-07-10", "one_week_move": 45.3, "four_week_move": 64.2, "twelve_week_move": 27.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.446778, "market_dynamics_buy_signal": false, "relative_strength": 0.527631, "fair_value_gap": -71.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 40.4688, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+45.3% over one week, +64.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 58, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 27}, {"label": "Market source", "count": 12}, {"label": "GlobeNewswire", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "TradingView", "count": 2}, {"label": "Insider Monkey", "count": 1}, {"label": "Investing.com", "count": 1}, {"label": "Moby", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 49}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 27}, {"label": "Earnings", "count": 21}, {"label": "Balance sheet", "count": 3}, {"label": "Guidance", "count": 2}, {"label": "Regulatory and legal", "count": 2}, {"label": "Analyst action", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "49", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+45.3% over one week, +64.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Cibus (CBUS) Welcomes Landmark EU Crop Breeding Decision"}], "updated_at": "2026-07-16T03:01:59.482693+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}